1. Home
  2. CPB vs LNTH Comparison

CPB vs LNTH Comparison

Compare CPB & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Campbell Soup Company

CPB

Campbell Soup Company

HOLD

Current Price

$20.08

Market Cap

6.2B

ML Signal

HOLD

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

HOLD

Current Price

$96.28

Market Cap

5.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPB
LNTH
Founded
1869
1956
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
5.6B
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
CPB
LNTH
Price
$20.08
$96.28
Analyst Decision
Hold
Buy
Analyst Count
18
6
Target Price
$26.06
$87.00
AVG Volume (30 Days)
6.4M
869.7K
Earning Date
06-01-2026
05-07-2026
Dividend Yield
7.63%
N/A
EPS Growth
6.35
N/A
EPS
1.13
1.80
Revenue
$10,253,000,000.00
$343,374,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.11
$14.19
P/E Ratio
$17.98
$51.90
Revenue Growth
6.40
3.62
52 Week Low
$19.76
$47.27
52 Week High
$35.00
$98.27

Technical Indicators

Market Signals
Indicator
CPB
LNTH
Relative Strength Index (RSI) 38.01 69.50
Support Level $19.90 $49.21
Resistance Level $21.46 $98.27
Average True Range (ATR) 0.62 3.22
MACD 0.00 0.21
Stochastic Oscillator 21.19 86.67

Price Performance

Historical Comparison
CPB
LNTH

About CPB Campbell Soup Company

Over the past 150-plus years, Campbell's has evolved into a leading domestic packaged food manufacturer, with a portfolio that extends beyond its iconic red-and-white labeled canned soup. In fiscal 2025 (July year-end), snacks accounted for 43% of its revenue, followed by soup (27%), other simple meals (23%), and beverages (7%). Beyond its namesake, its brands include Pepperidge Farm, Goldfish, Snyder's of Hanover, Swanson, Pacific Foods, Prego, Pace, V8, and, most recently, Rao's (a deal that closed in 2024). Around 90% of its revenue results from the US and the remainder from Canada and Latin America.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

Share on Social Networks: